Fig. 2: NKG2D-CAR transduction.
From: NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma
NKAE cells and CD45RA− T cells were transduced with an NKG2D-CAR. Representative dotplots are shown for NKAE cells (A) and CD45RA− T cells (B) transduction. Both cell types showed increased percentages of NKG2D-positive cells (over the percentage of untransduced cells) and median fluorescence intensity (MFI). The expression remained stable in CAR-expressing NKAE cells after 6 days; however, T cells showed more stable transduction (C). Results are shown as the mean ± SEM of five different experiments.
